Abstract
We have developed and validated a simple detection system with high‐performance liquid chromatography (HPLC) with positive ion electrospray ionization tandem mass spectrometry (ESI‐MS/MS) for determining cimetropium levels in human plasma using scopolamine butyl bromide as an internal standard (I.S.). The acquisition was performed in the multiple reaction monitoring (MRM) mode, by monitoring the transitions: m/z 357.9 > 103.1 for cimetropium and m/z 359.9 > 103.1 for butyl‐scopolamine. The method involves a simple single‐step liquid–liquid extraction with dichloromethane. The analyte was chromatographed on an YMC C18 reversed‐phase chromatographic column by isocratic elution with 10 mM ammonium formate buffer–methanol (19 : 81, v/v; adjusted to pH 4.0 with formic acid). The results were linear over the studied range (0.2–100 ng ml^−1^), with r^2^ = 1.0000, and the total analysis time for each run was 2 min. Intra‐ and interassay precisions were 0.70–8.54% and 1.08–4.85%, respectively, and intra‐ and interassay accuracies were 97.56–108.23% and 97.48–103.91%, respectively. The lower limit of quantification (LLOQ) was 0.2 ng ml^−1^. At this concentration, mean intra‐ and interassay precisions were 8.54% and 4.85%, respectively, and mean intra‐ and interassay accuracies were 97.56% and 98.91%, respectively. The mean recovery ranged from 62.71 ± 4.06 to 64.23 ± 2.32%. Cimetropium was found to be stable in plasma samples under typical storage and processing conditions. The devised assay was successfully applied to a pharmacokinetic study of cimetropium bromide administered as a single oral dose (150 mg) to healthy volunteers. Copyright © 2006 John Wiley & Sons, Ltd.